NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 54 min ago

Notice of Information: Additional Priorities for NCCIH Natural Product Clinical Trial Funding Opportunities

Tue, 2024-05-21 11:39
Notice NOT-AT-24-042 from the NIH Guide for Grants and Contracts

NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)

Tue, 2024-05-21 11:16
Funding Opportunity PAR-25-021 from the NIH Guide for Grants and Contracts. The purpose of the NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00) is to provide support and mentorship to outstanding students enrolled in integrated dual degree dental (DDS/DMD) and PhD programs during the transition from predoctoral student to postdoctoral scholar. This phased award program will facilitate completion of predoctoral dual degree dentist scientist training (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00). It is anticipated that successful completion of this phased award program will enhance dual degree dentist scientists' research career trajectories.

Request for Information (RFI): National Institute of Mental Health (NIMH) Strategic Plan Evaluation

Tue, 2024-05-21 04:44
Notice NOT-MH-24-135 from the NIH Guide for Grants and Contracts

Notice of Availability: Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning

Tue, 2024-05-21 04:43
Notice NOT-OD-24-125 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum

Tue, 2024-05-21 04:42
Notice NOT-OD-24-119 from the NIH Guide for Grants and Contracts

Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-25-185 and RFA-MH-25-186

Mon, 2024-05-20 13:02
Notice NOT-MH-24-330 from the NIH Guide for Grants and Contracts

HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)

Mon, 2024-05-20 02:47
Funding Opportunity RFA-ES-24-002 from the NIH Guide for Grants and Contracts. NIEHS invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response within the Department of Energy (DOE) nuclear weapons complex. The aim of this funding opportunity is to prevent work-related harm through safety and health training. The training programs consist of information and practical exercises with the objective of raising the knowledge of workers in protecting themselves and the community from being exposed to hazardous materials encountered during hazardous waste operations; facility decommissioning and decontamination; hazardous materials transportation; environmental restoration of contaminated facilities; or chemical emergency response. Currently, tens of thousands of DOE employees are required to complete safety and health training. The goal of this training is to help reduce the risk of workers being exposed during work activities to hazardous materials and hazardous waste products. The NIEHS/DOE Nuclear Worker Training Program enhances training capabilities at these sites.

Request for Information (RFI): NIGMS Mature Synchrotron Program Evaluation

Fri, 2024-05-17 12:53
Notice NOT-GM-24-019 from the NIH Guide for Grants and Contracts

Notice of Changes in NCI K00 Salary Caps in The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

Fri, 2024-05-17 03:33
Notice NOT-CA-24-054 from the NIH Guide for Grants and Contracts

Access and Manipulation of Brain Cell Subtypes Implicated in Aging and AD/ADRD (R61/R33 Clinical Trial Not allowed)

Thu, 2024-05-16 11:01
Funding Opportunity RFA-AG-25-024 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications proposing innovative strategies to target and manipulate brain cell subtypes that are altered in aging, Alzheimer's Disease (AD), and AD-Related Dementias (ADRDs). ADRDs include frontotemporal disorders (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and multiple etiology dementias (MED). Specifically, the goal of the NOFO is to encourage the development and utilization of sophisticated tools that pair breakthroughs in adeno-associated virus (AAV) capsid engineering with enhancer element identification to (1) optimize precise targeting of disease-relevant cell subtypes in aged and degenerating mammalian brains and (2) monitor and/or manipulate these cells in vivo to address mechanistic hypotheses related to brain aging and AD/ADRD in animals models. To achieve this goal, the NOFO utilizes the R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for pilot activities to demonstrate proof-of-principle. The R33 phase provides up to 3 years of support for implementation activities including hypothesis testing.

NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional)

Thu, 2024-05-16 03:18
Funding Opportunity RFA-EY-24-003 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate translational efforts in developing and implementing accessibility devices or interventions that apply new technologies to address challenges faced by individuals living with visual impairment. Critical elements of applications include a clear set of milestones that support development and testing of the tool, device, or intervention proposed; multidisciplinary and collaborative teams that include individuals with lived experience; and a tractable dissemination plan. The overall goal of the program is to push the boundaries of innovation in technology development to address accessibility needs of individuals with visual impairment and create resources that will be made available to the community. This NOFO uses a milestone driven and phased mechanism of award. Initial technology development and feasibility activities (R61 phase) may transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. All applications must address both R61 and R33 phases.

Pages